Youcare Pharmaceutical Group Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Youcare Pharmaceutical Group Co., Ltd.

Why is Youcare Pharmaceutical Group Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -14.99% and Operating profit at -183.81% over the last 5 years

The company has declared negative results for the last 2 consecutive quarters

INTEREST(HY) At CNY 14.86 MM has Grown at 27.51%
NET SALES(Q) At CNY 591.72 MM has Fallen at -21.06%
PRE-TAX PROFIT(Q) At CNY -57.82 MM has Fallen at -141.47%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 24.35%, its profits have fallen by -204.1%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Youcare Pharmaceutical Group Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Youcare Pharmaceutical Group Co., Ltd.

21.39%

0.06

71.08%

China Shanghai Composite

16.67%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-14.99%

EBIT Growth (5y)

-183.81%

EBIT to Interest (avg)

71.91

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.86

Tax Ratio

81.53%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

14.13%

ROE (avg)

7.99%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.89

EV to EBIT

-80.76

EV to EBITDA

98.82

EV to Capital Employed

3.18

EV to Sales

3.24

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.93%

ROE (Latest)

-2.91%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-41What is not working for the Company

INTEREST(HY)

At CNY 14.86 MM has Grown at 27.51%

NET SALES(Q)

At CNY 591.72 MM has Fallen at -21.06%

PRE-TAX PROFIT(Q)

At CNY -57.82 MM has Fallen at -141.47%

NET PROFIT(Q)

At CNY -49.41 MM has Fallen at -105.86%

OPERATING CASH FLOW(Y)

Lowest at CNY 178.47 MM

ROCE(HY)

Lowest at -6.6%

RAW MATERIAL COST(Y)

Grown by 20.94% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -16.82 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.21 times

OPERATING PROFIT(Q)

Lowest at CNY -65.2 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -11.02 %

Here's what is not working for Youcare Pharmaceutical Group Co., Ltd.

Interest

At CNY 14.86 MM has Grown at 27.51%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 591.72 MM has Fallen at -21.06%

over average net sales of the previous four periods of CNY 749.56 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -57.82 MM has Fallen at -141.47%

over average net sales of the previous four periods of CNY -23.95 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -49.41 MM has Fallen at -105.86%

over average net sales of the previous four periods of CNY -24 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 178.47 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY -65.2 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -11.02 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at -16.82 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 3.21 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 20.94% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales